Detalles de la búsqueda
1.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
N Engl J Med
; 385(23): 2150-2160, 2021 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449183
2.
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer.
Future Oncol
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592002
3.
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
Oncologist
; 28(6): e425-e435, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36869793
4.
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis.
J Surg Oncol
; 126(8): 1520-1532, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006054
5.
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
Eur Heart J
; 41(47): 4497-4504, 2020 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860041
6.
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Lancet
; 394(10206): 1335-1343, 2019 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31492505
7.
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
BMC Cardiovasc Disord
; 19(1): 165, 2019 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31299906
8.
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Thromb J
; 16: 9, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29719492
9.
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Thromb J
; 16: 18, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29855634
10.
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry.
Thromb J
; 13: 41, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26500458
11.
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
Int J Cardiol
; : 132118, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697397
12.
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care.
Eur Heart J Cardiovasc Pharmacother
; 9(1): 47-57, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35881467
13.
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis.
Clin Res Cardiol
; 110(6): 831-840, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098470
14.
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study.
Orphanet J Rare Dis
; 16(1): 191, 2021 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926503
15.
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study.
Eur Heart J Cardiovasc Pharmacother
; 7(FI1): f30-f39, 2021 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32790837
16.
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study.
Clin Cardiol
; 43(7): 769-780, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406557
17.
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
Thromb Res
; 196: 297-304, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32950897
18.
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries.
Eur J Intern Med
; 82: 48-55, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32826158
19.
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study.
J Cardiovasc Med (Hagerstown)
; 20(2): 97-104, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30540648
20.
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design.
Clin Cardiol
; 42(12): 1147-1154, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650560